Kendra S. Carmon

2.8k citations

40 papers · 2.1k indexed · 1 hit paper · h-index 21

Co-authors: Xing Gong Anthony Thomas Qingyun Liu Qiushi Lin David S. Loose Jing Yi Ali Azhdarinia Ling Wu
Topics: Wnt/β-catenin signaling in development and cancer (13 papers)Cancer Cells and Metastasis (9 papers)HER2/EGFR in Cancer Research (9 papers)
Cited by: Oncology Molecular Biology Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Biological ChemistrySHILAP Revista de lepidopterología
Partner nations: United States Bulgaria Canada

In The Last Decade

Kendra S. Carmon

39 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling

2011 690 citations Kendra S. Carmon, Xing Gong et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Kendra S. Carmon

Since Specialization

Citations

This map shows the geographic impact of Kendra S. Carmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendra S. Carmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendra S. Carmon more than expected).

Fields of papers citing papers by Kendra S. Carmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendra S. Carmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendra S. Carmon. The network helps show where Kendra S. Carmon may publish in the future.

Co-authorship network of co-authors of Kendra S. Carmon

This figure shows the co-authorship network connecting the top 25 collaborators of Kendra S. Carmon. A scholar is included among the top collaborators of Kendra S. Carmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendra S. Carmon. Kendra S. Carmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models 2025 ·Cell Reports Medicine ·(unknown),Zhengdong Liang,(unknown),(unknown),(unknown),(unknown),Yukimatsu Toh,Kendra S. Carmon	0
2	G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors 2024 ·Cellular and Molecular Life Sciences ·(unknown),(unknown),(unknown),Brian J. Holleran,Charlotte Avet,(unknown),(unknown),Christine Lavoie,Kendra S. Carmon,Michel Bouvier,Richard Leduc	1
3	Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells 2023 ·Molecular Cancer Therapeutics ·(unknown),(unknown),(unknown),(unknown),Liezl E. Francisco,Zhengdong Liang,Kendra S. Carmon	10
4	G protein-coupled receptor-targeting antibody-drug conjugates: Current status and future directions 2023 ·Cancer Letters ·(unknown),Kendra S. Carmon	7
5	LGR4 and LGR5 form distinct homodimers that only LGR4 complexes with RNF43/ZNRF3 to provide high affinity binding of R-spondin ligands 2023 ·Scientific Reports ·Yukimatsu Toh,Ling Wu,Soo-Hyun Park,(unknown),Jianghua Tu,Wangsheng Yu,Mingxin Zuo,Kendra S. Carmon,(unknown)	9
6	GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism 2019 ·Molecular Cancer Research ·Sheng Zhang,(unknown),(unknown),Ling Wu,(unknown),Kendra S. Carmon	39
7	The most common RNF43 mutant G659Vfs41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis 2019 ·Scientific Reports* ·Jianghua Tu,Soo-Hyun Park,Wangsheng Yu,Sheng Zhang,Ling Wu,Kendra S. Carmon,(unknown)	46
8	Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization 2018 ·Cancer Research ·Binghe Tan,(unknown),Jie Zhang,Juliang Qin,Na Zhang,Hua Ren,Min Qian,Stefan Siwko,Kendra S. Carmon,Qingyun Liu,Honghui Han,Bing Du,Mingyao Liu	132
9	Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody–Drug Conjugates 2018 ·Molecular Pharmaceutics ·Ali Azhdarinia,(unknown),Sukhen C. Ghosh,(unknown),(unknown),Jie Cui,Wangsheng Yu,Qingyun Liu,Kendra S. Carmon	18
10	Differential activities and mechanisms of the four R-spondins in potentiating Wnt/β-catenin signaling 2018 ·Journal of Biological Chemistry ·Soo-Hyun Park,Jie Cui,Wangsheng Yu,Ling Wu,Kendra S. Carmon,(unknown)	69
11	Synthesis of a Fluorescently Labeled ⁶⁸Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting 2017 ·ACS Medicinal Chemistry Letters ·Sukhen C. Ghosh,(unknown),Melissa Rodríguez,Susanne Kossatz,(unknown),Kendra S. Carmon,Thomas Reiner,Agnes Schönbrunn,Ali Azhdarinia	28
12	A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting 2017 ·Journal of Nuclear Medicine ·Sukhen C. Ghosh,Melissa Rodríguez,Kendra S. Carmon,(unknown),Nathaniel Wilganowski,Agnes Schönbrunn,Ali Azhdarinia	9
13	LGR5 receptor promotes cell–cell adhesion in stem cells and colon cancer cells via the IQGAP1–Rac1 pathway 2017 ·Journal of Biological Chemistry ·Kendra S. Carmon,Xing Gong,Jing Yi,Ling Wu,Anthony Thomas,Catherine M. Moore,Ikuo Masuho,David J. Timson,Kirill A. Martemyanov,(unknown)	60
14	LGR5-Targeted Antibody–Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence 2016 ·Molecular Cancer Therapeutics ·Xing Gong,Ali Azhdarinia,Sukhen C. Ghosh,Wei Xiong,Zhiqiang An,Qingyun Liu,Kendra S. Carmon	84
15	Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness 2014 ·Oncogene ·(unknown),Jing Yi,Kendra S. Carmon,Christine Crumbley,Wei Xiong,Alexandra Thomas,Xueying Fan,Shuai Guo,Zhiqiang An,John T. Chang,(unknown)	59
16	LGR6 Is a High Affinity Receptor of R-Spondins and Potentially Functions as a Tumor Suppressor 2012 ·PLoS ONE ·Xing Gong,Kendra S. Carmon,Qiushi Lin,Anthony Thomas,Jing Yi,Qingyun Liu	98
17	R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signalingbreakdown → 2011 ·Proceedings of the National Academy of Sciences ·Kendra S. Carmon,Xing Gong,Qiushi Lin,Anthony Thomas,Qingyun Liu	690
18	Development of a bioassay for detection of Wnt-binding affinities for individual frizzled receptors 2010 ·Analytical Biochemistry ·Kendra S. Carmon,David S. Loose	32
19	Wnt7a interaction with Fzd5 and detection of signaling activation using a split eGFP 2008 ·Biochemical and Biophysical Research Communications ·Kendra S. Carmon,David S. Loose	29
20	A biosensor for estrogenic substances using the quartz crystal microbalance 2005 ·Analytical Biochemistry ·Kendra S. Carmon,Ruth E. Baltus,Linda A. Luck	23

About Kendra S. Carmon

Kendra S. Carmon is a scholar working on Oncology, Sensory Systems and Radiology, Nuclear Medicine and Imaging, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (13 papers), Cancer Cells and Metastasis (9 papers) and HER2/EGFR in Cancer Research (9 papers). The work is most often cited by research in Oncology (750 citations), Molecular Biology (1.4k citations) and Cancer Research (202 citations). Kendra S. Carmon has collaborated with scholars based in United States, Bulgaria and Canada. Frequent co-authors include Xing Gong, Anthony Thomas, Qingyun Liu, Qiushi Lin, David S. Loose, Jing Yi, Ali Azhdarinia, Ling Wu, Linda A. Luck and Ruth E. Baltus. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact